Cloning of a kallikrein-like enzyme originated from dog heart and investigation of its intracellular localization and expression regulation.

狗心脏类激肽释放酶样酶的克隆及其细胞内定位和表达调控的研究。

基本信息

  • 批准号:
    10670692
  • 负责人:
  • 金额:
    $ 1.66万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

We have previously shown that the purified kinin-forming enzyme from the dog heart is similar to tissue kallikrein and is also able to convert angiotensin (Ang) I to Ang II. The aim of the present study is to clarify the cloning, intracellular localization and expression regulation of this enzyme. Western blot analysis indicated the presence of this enzyme not only the heart (atria, ventricle, coronary artery) but also other tissues such as aorta, kidney, pancreas, small intestine, and skeletal muscle. Its presence was also demonstrated in MDCK cell originated from canine distal tubules. The kallikrein-like enzyme has been purified from homogenates of the kidney and aorta by a DEAE-Sepharose and aprotinin affinity column. Purified enzyme from the kidney and aorta was visualized at the relative molecular weight of 65 kDa on Western blotting which is identical to that of the kallikrein-like enzyme purified from the heart. The purified enzyme from the heart was proceeded to amino acid composition and sequence analysis. It has N-terminal blocked amino acid. The amino acid composition of purified kallikrein-like enzyme from the heart was different from that of dog urinary and pancreatic kallikrein. Autolysed samples of this enzyme were electroblotted to the membrane, and cutted membrane including one band was proceeded to amino acid sequence analysis. Three sets of partial amino acid sequence were obtained. These sequences are different to the hitherto known kallikrein. Mixed primer was newly made, and cDNA library from the dog heart was also newly prepared. At the present, DNA sequence analysis is now ongoing. This enzyme may play an important role in cardiovascular systems through generating kinins and Ang II.
我们先前已经证明,从狗心脏中纯化的激动素形成酶类似于组织激肽释放酶,并且能够将血管紧张素(Ang)I转化为Ang II。本研究的目的是阐明该酶的克隆、细胞内定位和表达调控。Western印迹分析表明,该酶不仅在心脏(心房、心室、冠状动脉)中存在,而且在其他组织中也存在,如主动脉、肾脏、胰腺、小肠和骨骼肌。在犬远端小管来源的MDCK细胞中也有表达。用DEAE-Sepharose和抑肽酶亲和层析柱从肾和主动脉匀浆中纯化了激肽释放酶样酶。Western blotting显示肾脏和主动脉中的纯化酶的相对分子质量为65 kDa,这与从心脏中纯化的激肽释放酶的相对分子质量相同。对纯化的心脏酶进行氨基酸组成和序列分析。它含有N端封闭的氨基酸。纯化的心脏激肽释放酶的氨基酸组成不同于狗的尿激肽释放酶和胰腺激肽释放酶。将该酶的自溶样品电印迹到膜上,切割成一条带的膜进行氨基酸序列分析。获得了三组部分氨基酸序列。这些序列与迄今已知的激肽释放酶不同。设计了新的混合引物,并新制备了犬心脏的cDNA库。目前,DNA序列分析正在进行中。这种酶可能通过产生激动素和血管紧张素II在心血管系统中发挥重要作用。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
"M.Sasaguri,et al" Structure of kalikrein-like enzyme and its tissue localization in the dog.(Abstract). J Hypertens. 1998 (16 Suppl 2)
“M.Sasaguri,et al”类激肽释放酶的结构及其在狗体内的组织定位。(摘要)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sasaguri M. et al: "Structure of kallikrein-like enzyme and its tissue localization in the dog."Immuhopharmacology. vol 44. 15-19 (1999)
Sasaguri M. 等人:“激肽释放酶样酶的结构及其在狗体内的组织定位。”免疫药理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S140: "M.Sasaguri,et al" Structure of a kallikrein-like enzyme and its tissue localization in the dog.Immunopharmacology. 1999 ((in press))
S140:“M.Sasaguri 等人”激肽释放酶样酶的结构及其在狗体内的组织定位。免疫药理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SASAGURI Manabu其他文献

SASAGURI Manabu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SASAGURI Manabu', 18)}}的其他基金

Cloning of a kinin-tensin enzyme and kinin-destruction enzyme in the dog heart
狗心脏中激肽-张力蛋白酶和激肽破坏酶的克隆
  • 批准号:
    08670838
  • 财政年份:
    1996
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of kinin generating enzyme in the cardiovascular system.
心血管系统中激肽生成酶的研究。
  • 批准号:
    06670754
  • 财政年份:
    1994
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
  • 批准号:
    10667764
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
Nanocrystal Quantum Dot Biomimetics of SARS-CoV-2 to Interrogate Neutrophil-Mediated Neuroinflammation at the Blood-Brain Barrier
SARS-CoV-2 的纳米晶量子点仿生学研究中性粒细胞介导的血脑屏障神经炎症
  • 批准号:
    10510611
  • 财政年份:
    2022
  • 资助金额:
    $ 1.66万
  • 项目类别:
KININ2018CLE
基宁2018CLE
  • 批准号:
    9471651
  • 财政年份:
    2018
  • 资助金额:
    $ 1.66万
  • 项目类别:
Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
  • 批准号:
    9023669
  • 财政年份:
    2015
  • 资助金额:
    $ 1.66万
  • 项目类别:
Mechanisms of IL-17 Mediated Host Defense in the Kidney
IL-17 介导的肾脏宿主防御机制
  • 批准号:
    9144776
  • 财政年份:
    2015
  • 资助金额:
    $ 1.66万
  • 项目类别:
Role of kallikreins in lupus
激肽释放酶在狼疮中的作用
  • 批准号:
    9121460
  • 财政年份:
    2014
  • 资助金额:
    $ 1.66万
  • 项目类别:
Role of kallikreins in lupus
激肽释放酶在狼疮中的作用
  • 批准号:
    8928481
  • 财政年份:
    2014
  • 资助金额:
    $ 1.66万
  • 项目类别:
Urinary Angiotensinogen Excretion and Salt-Sensitivity of Blood Pressure
尿血管紧张素原排泄和血压的盐敏感性
  • 批准号:
    8697725
  • 财政年份:
    2014
  • 资助金额:
    $ 1.66万
  • 项目类别:
Mitochondrial Dysfunction in Chronic Kidney Disease
慢性肾脏病的线粒体功能障碍
  • 批准号:
    8735140
  • 财政年份:
    2013
  • 资助金额:
    $ 1.66万
  • 项目类别:
Mitochondrial Dysfunction in Chronic Kidney Disease
慢性肾脏病的线粒体功能障碍
  • 批准号:
    8617984
  • 财政年份:
    2013
  • 资助金额:
    $ 1.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了